#185 – Allan Sniderman, M.D.: Cardiovascular disease and why we should change the way we assess risk
“If we’re still saying the same things we said 30 years ago, it could be a problem because we should have learned how to say it better, more accurately.” —Allan Sniderman
LDL-C & systolic blood pressure and lifetime risk of cardiovascular disease
Mendelian randomization and lifetime cardiovascular disease risk.